Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
In HFF cells, SM‐102 LNPs incorporating retinol, riboflavin, and tocopherol as a fifth component, as well as 306Oi10 LNPs with retinol, riboflavin, and cholecalciferol, achieved transfection levels several‐fold higher than control LNPs and other ENDO LNPs (Figure 2B).
Source: Results and Discussion. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Reengineering Endogenous Targeting Lipid Nanoparticles (ENDO) for Systemic Delivery of mRNA to Pancreas
Study design awaiting verification · Advanced Materials (Deerfield Beach, Fla.) · 2025
Original publication title
Reengineering Endogenous Targeting Lipid Nanoparticles (ENDO) for Systemic Delivery of mRNA to Pancreas
© 2025 The Author(s). Advanced Materials published by Wiley‐VCH GmbH
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
Abstract
Lipid nanoparticles (LNPs) hold transformative potential for nucleic acid delivery, with applications ranging from clinical use, particularly in COVID‐19 vaccines, to gene therapy and cancer immunotherapy. However, a major limitation lies in their preferential accumulation in the liver following intravenous administration, making most targets hard‐to‐reach. In this study, a novel platform called endogenous targeting lipid nanoparticles (ENDO), containing cholecalciferol (vitamin D3) as a fifth component is reported, that selectively delivers mRNA to the pancreas: a target previously inaccessible through intravenous administration.
The top formulation, C‐CholF3, demonstrates an unprecedented 99% pancreas selectivity with robust and sustained protein expression for up to 3 days in a dose‐dependent manner with minimal toxicity that makes it suitable for repeat administration. This organ‐specific delivery is proposed to be mediated by an endogenous targeting mechanism involving the Vitamin D receptor (VDR). C‐CholF3 also enables selective pancreatic delivery of plasmid DNA and circular mRNA, underscoring its versatility and therapeutic potential. Furthermore, C‐CholF3 exhibits pancreas‐specific gene editing in the Ai14 transgenic mouse model, showing high expression of tdTomato in the β cells.
These findings highlight its potential for translational applications in protein replacement and CRISPR/Cas9‐mediated gene editing for currently incurable pancreatic diseases, including pancreatic cancer and diabetes.
Authors’ abstract
Abstract
Lipid nanoparticles (LNPs) hold transformative potential for nucleic acid delivery, with applications ranging from clinical use, particularly in COVID‐19 vaccines, to gene therapy and cancer immunotherapy. However, a major limitation lies in their preferential accumulation in the liver following intravenous administration, making most targets hard‐to‐reach. In this study, a novel platform called endogenous targeting lipid nanoparticles (ENDO), containing cholecalciferol (vitamin D3) as a fifth component is reported, that selectively delivers mRNA to the pancreas: a target previously inaccessible through intravenous administration.
The top formulation, C‐CholF3, demonstrates an unprecedented 99% pancreas selectivity with robust and sustained protein expression for up to 3 days in a dose‐dependent manner with minimal toxicity that makes it suitable for repeat administration. This organ‐specific delivery is proposed to be mediated by an endogenous targeting mechanism involving the Vitamin D receptor (VDR). C‐CholF3 also enables selective pancreatic delivery of plasmid DNA and circular mRNA, underscoring its versatility and therapeutic potential. Furthermore, C‐CholF3 exhibits pancreas‐specific gene editing in the Ai14 transgenic mouse model, showing high expression of tdTomato in the β cells.
These findings highlight its potential for translational applications in protein replacement and CRISPR/Cas9‐mediated gene editing for currently incurable pancreatic diseases, including pancreatic cancer and diabetes.
Publication and source details
Original title: Reengineering Endogenous Targeting Lipid Nanoparticles (ENDO) for Systemic Delivery of mRNA to Pancreas
Ivan Isaac; Luv Patel; Nguyen Tran; Amarnath Singam; DongSoo Yun; Prasun Guha; Seungman Park; Chandrabali Bhattacharya
Advanced Materials (Deerfield Beach, Fla.) · 2025
* E‐mail: chandra.bhattacharya@unlv.edu© 2025 The Author(s). Advanced Materials published by Wiley‐VCH GmbHhttps://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. Pharmaceutical Research and Manufacturers of America Foundation10.13039/100001797 2024 FSGDL 1170646 National Institute on Aging10.13039/100000049 K25AG070286 NIH COBRE 5P20GM121325 Nanotechnology Materials Core Facility SCR_018674 Koch Institute Support Core, National Cancer Institute P30‐CA14051
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T01:38:19.347184+00:00
DOI: 10.1002/adma.202507657 · PMC12510295